期刊文献+

左氧氟沙星治疗社区获得性肺炎临床评价及对炎症因子的影响 被引量:1

Clinical evaluation of Levofloxacin in the treatment of community acquired pneumonia and its effect on serum Creactive protein
下载PDF
导出
摘要 目的探讨左氧氟沙星在社区获得性肺炎治疗中的应用效果及对患者炎症因子的影响。方法选取2016年1月—2017年12月于我院就诊的社区获得性肺炎患者80例,随机等分为观察组(n=40)与对照组(n=40),对照组予以阿奇霉素治疗,观察组在此基础上联合左氧氟沙星治疗,对比2组治疗效果及炎症因子水平。结果观察组患者的治疗总有效率显著高于对照组(P<0.05)。观察组患者的发热、咳痰、肺部啰音、喘鸣音消失时间显著短于对照组(P<0.05);观察组患者治疗后的TNF-α、IL-5、MMP-2、PCT水平显著低于对照组(P<0.05)。结论左氧氟沙星可改善社区获得性肺炎患者的临床症状及体征,减轻患者的炎症状态,疗效良好,值得临床借鉴推广。 Objective To investigate the effect of levofloxacin in the treatment of community acquired pneumonia and its influence on inflammatory factors. Methods 80 patients with community-acquired pneumonia in our hospital from Januany 2016 to December 2017 were divided into observation group and eonlrol group.The control group was given azithromyein.The observation group was treated with azithromyein combined with levofloxaein, and the therapeutic effeets and levels of inflammatory factors were compared between the two groups. Results The lotal effective rate of the observation group was significantly higher than that of the control group (P〈0.05).The disappearance time of fever, cough, lung snoring and wheezing in the observation group was significantly shorter than that in the control group (P〈0.05).The levels of TNF-a, IL-5, MMP-2 and PCT in the observation group were significantly lower than those in the control group (P〈0.05).Conclusion Levofloxacin is effective in the treatment of community-acquired pneumonia, and reducing the inflammatory state of the patients, the clinical curative effect is good, so it is worth clinical reierence and promotion
作者 周金林 Zhou Jinlin(The Central Hospital of Bazhong City,Bazhong,Sichuan 63600)
机构地区 巴中市中心医院
出处 《基层医学论坛》 2018年第31期4373-4374,共2页 The Medical Forum
关键词 社区获得性肺炎 左氧氟沙星 疗效 炎症因子 Community acquired pneumonia Levofloxaein Curative effect Inflammatory factors
  • 相关文献

参考文献7

二级参考文献57

  • 1李莉,陈晨,曾武章.莫西沙星治疗老年社区获得性肺炎的疗效及相关因素分析[J].中国生化药物杂志,2014,34(1):127-129. 被引量:32
  • 2孟召伟,方佩华.细胞间黏附分子-1临床应用的研究进展[J].天津医药,2004,32(11):714-716. 被引量:3
  • 3中华医学会,中华医院管理学会药事管理专业委员会,中国药学会医院药学专业委员会.抗菌药物临床应用指导原则[J].中华医学杂志,2004,84(23):2026-2056. 被引量:141
  • 4社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3041
  • 5Manelell LA,Wunderink RG,Anzuetoet A,et al. Infectious Disease Society of American/American Thoracic Society consensus guide- lines on the management of community-acquired pneumonia in a- dults [ J ]. Clin Infect Dis,2007,44 (2) : S27 - S72.
  • 6Musher DM, Thorner AR. Community - acquired pneumonia[ J ]. N Engl J Med, 2014,371:1619 -1628.
  • 7Chakravorty SJ, Craig A. The role of ICAM - l in Plas- modium falciparum cytoadherence [ J ]. Eur J Cell Biol, 2005,84 ( 1 ) : 15 - 27.
  • 8Lyons PD, Benveniste EN. Cleavage of membrane - as- sociated ICAM - 1 from astrocytes: involvement of a metalloprotease [ J ]. Glia, 1998,22 (2) : 103 - 112.
  • 9Hansen AB, Verder H, Staun - Olsen P. Soluble inter- cellu!ar adhesion molecule and C - reactive protein as early markers of infection in newborns [ J]. J PerinatMed,2000,28(2):97-103.
  • 10Falguera M, Trujilano J, Caro S. A prediction rule for esti- mating the risk bacteremia in patients with community-ac- quired pneumonia[ J] .2009, 8(3) : 125- 127.

共引文献106

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部